Comparison of Efficacy of Regional and Extensive Clinical Target Volumes in Postoperative Radiotherapy for Esophageal Squamous Cell Carcinoma
Xiaohong Qiao,W. Wang,Z. Zhou,X. Gao,J.Y. Chang
DOI: https://doi.org/10.1016/j.ijrobp.2007.07.1301
2007-01-01
Abstract:Purpose/Objective(s)The optimal CTV for postoperative RT in esophageal cancer remains controversial. In addition to local invasion and vertical spread along the esophagus, esophageal carcinoma tends to show spread to the downstream regional lymph nodes and sometimes spreads widely over various anatomic sites even in early-stage disease. Radiation oncologists once designed postoperative RT portals to encompass an extensive field of surgical bed and lymph node stations; however, this approach confers numerous and severe side effects. We hypothesized that postoperative RT ports used to cover the tumor bed and downstream regional lymph nodes would confer the same survival benefit as the extended-field approach but without the same rate of serious side effects. We compared the effects of these 2 different CTVs on survival after postoperative RT for esophageal SCC.Materials/MethodsWe retrospectively studied 102 patients who underwent postoperative RT after radical resection for esophageal SCC (T3/4 or N1) with negative margin at a radiation dose of at least 50 Gy. In the extensive-portal group (group E, 43 patients treated between 1992–1995), the CTV encompassed a the bilateral supraclavicular region, all mediastinal lymph nodes, the anastomosis site, and the left gastric and paracardial lymphatics. In the regional-portal group (group R, 59 patients treated 1995–1997), the CTV was confined to the tumor bed and the lymph nodes in the immediate region of the primary lesion. One-, 3-, and 5-year survival rates were compared between the groups and multivariate/univariate analyses for factors predicting survival were studied.ResultsFor the entire group, the 1-, 3- and 5-year survival rates were 76.3%, 50.5%, and 42.9%, respectively (median survival, 30 months). The 1-, 3-, and 5-year survival rates were 76.5%, 52.1%, and 41.3%, respectively, in the E group and 76.2%, 49.2%, and 44.6%, respectively, in the R group (not significant). The local-regional control rate was similar between the groups, and the toxicity profile favored the R group. According to the multivariate analysis, N stage, number of lymph nodes with metastatic disease, and tumor length were the independent prognostic factors for survival.ConclusionsIn the treatment of esophageal SCC, regional-portal postoperative RT does not compromise survival compared with extensive-portal RT; therefore, the regional-portal scheme should be considered in patients with radical resection and negative margin. N stage, number of affected lymph nodes, and tumor length predicts poor survival. Purpose/Objective(s)The optimal CTV for postoperative RT in esophageal cancer remains controversial. In addition to local invasion and vertical spread along the esophagus, esophageal carcinoma tends to show spread to the downstream regional lymph nodes and sometimes spreads widely over various anatomic sites even in early-stage disease. Radiation oncologists once designed postoperative RT portals to encompass an extensive field of surgical bed and lymph node stations; however, this approach confers numerous and severe side effects. We hypothesized that postoperative RT ports used to cover the tumor bed and downstream regional lymph nodes would confer the same survival benefit as the extended-field approach but without the same rate of serious side effects. We compared the effects of these 2 different CTVs on survival after postoperative RT for esophageal SCC. The optimal CTV for postoperative RT in esophageal cancer remains controversial. In addition to local invasion and vertical spread along the esophagus, esophageal carcinoma tends to show spread to the downstream regional lymph nodes and sometimes spreads widely over various anatomic sites even in early-stage disease. Radiation oncologists once designed postoperative RT portals to encompass an extensive field of surgical bed and lymph node stations; however, this approach confers numerous and severe side effects. We hypothesized that postoperative RT ports used to cover the tumor bed and downstream regional lymph nodes would confer the same survival benefit as the extended-field approach but without the same rate of serious side effects. We compared the effects of these 2 different CTVs on survival after postoperative RT for esophageal SCC. Materials/MethodsWe retrospectively studied 102 patients who underwent postoperative RT after radical resection for esophageal SCC (T3/4 or N1) with negative margin at a radiation dose of at least 50 Gy. In the extensive-portal group (group E, 43 patients treated between 1992–1995), the CTV encompassed a the bilateral supraclavicular region, all mediastinal lymph nodes, the anastomosis site, and the left gastric and paracardial lymphatics. In the regional-portal group (group R, 59 patients treated 1995–1997), the CTV was confined to the tumor bed and the lymph nodes in the immediate region of the primary lesion. One-, 3-, and 5-year survival rates were compared between the groups and multivariate/univariate analyses for factors predicting survival were studied. We retrospectively studied 102 patients who underwent postoperative RT after radical resection for esophageal SCC (T3/4 or N1) with negative margin at a radiation dose of at least 50 Gy. In the extensive-portal group (group E, 43 patients treated between 1992–1995), the CTV encompassed a the bilateral supraclavicular region, all mediastinal lymph nodes, the anastomosis site, and the left gastric and paracardial lymphatics. In the regional-portal group (group R, 59 patients treated 1995–1997), the CTV was confined to the tumor bed and the lymph nodes in the immediate region of the primary lesion. One-, 3-, and 5-year survival rates were compared between the groups and multivariate/univariate analyses for factors predicting survival were studied. ResultsFor the entire group, the 1-, 3- and 5-year survival rates were 76.3%, 50.5%, and 42.9%, respectively (median survival, 30 months). The 1-, 3-, and 5-year survival rates were 76.5%, 52.1%, and 41.3%, respectively, in the E group and 76.2%, 49.2%, and 44.6%, respectively, in the R group (not significant). The local-regional control rate was similar between the groups, and the toxicity profile favored the R group. According to the multivariate analysis, N stage, number of lymph nodes with metastatic disease, and tumor length were the independent prognostic factors for survival. For the entire group, the 1-, 3- and 5-year survival rates were 76.3%, 50.5%, and 42.9%, respectively (median survival, 30 months). The 1-, 3-, and 5-year survival rates were 76.5%, 52.1%, and 41.3%, respectively, in the E group and 76.2%, 49.2%, and 44.6%, respectively, in the R group (not significant). The local-regional control rate was similar between the groups, and the toxicity profile favored the R group. According to the multivariate analysis, N stage, number of lymph nodes with metastatic disease, and tumor length were the independent prognostic factors for survival. ConclusionsIn the treatment of esophageal SCC, regional-portal postoperative RT does not compromise survival compared with extensive-portal RT; therefore, the regional-portal scheme should be considered in patients with radical resection and negative margin. N stage, number of affected lymph nodes, and tumor length predicts poor survival. In the treatment of esophageal SCC, regional-portal postoperative RT does not compromise survival compared with extensive-portal RT; therefore, the regional-portal scheme should be considered in patients with radical resection and negative margin. N stage, number of affected lymph nodes, and tumor length predicts poor survival.